![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
IsoPlexis Corporation | NASDAQ:ISO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.7616 | 0.8468 | 0.79 | 0 | 01:00:00 |
RNS Number:8341R Isotron PLC 07 November 2003 Isotron Plc (the "Company") Director Shareholdings John Barker (Chief Executive) has exercised an option to subscribe for 10,000 ordinary shares in the Company at 315 p per share on the 7 November 2003. Following the exercise, John Barker sold 8,500 ordinary shares at 440p per share in order to fund the cost of exercising this option and the personal tax liability arising on exercise. This sale also took place on 7 November. As a result of the above exercise, John Barker has increased his beneficial interest in the Company from 28,243 ordinary shares to 29,743 ordinary shares. Paul Wynne (Finance Director) has exercised an option to subscribe for 10,000 ordinary shares in the Company at 315 p per share on the 7 November 2003. Following the exercise, Paul Wynne sold 8,500 ordinary shares at 440p per share in order to fund the cost of exercising this option and the personal tax liability arising on exercise. This sale also took place on 7 November. As a result of the above exercise, Paul Wynne has increased his beneficial interest in the Company from 11,655 ordinary shares to 13,155 ordinary shares. John Woolston (Regional Director) has exercised an option to subscribe for 10,000 ordinary shares in the Company at 315 p per share on the 7 November 2003. Following the exercise, John Woolston sold 8,500 ordinary shares at 440p per share in order to fund the cost of exercising this option and the personal tax liability arising on exercise. This sale also took place on 7 November. As a result of the above exercise, John Woolston has increased his beneficial interest in the Company from 16,143 ordinary shares to 17,643 ordinary shares. Jonathan Azis (Chairman) has also increased his interest in the ordinary share capital of the Company through the purchase of 619 shares at a price of 440p per share. This purchase took place on 7 November 2003. As a result of the above purchase, Jonathan Azis now has a beneficial interest in 3,000 ordinary shares of 25p. Giles Weaver (Non-Executive Director) also purchased 10,000 shares at a price of 440p per share. This purchase took place on 7 November 2003. As a result of the above purchase, Giles Weaver now has a beneficial interest in 10,000 ordinary shares of 25p. The issued share capital of the Company is 21,072,500 ordinary shares of 25p. C E Bray, Assistant Company Secretary 01793 567900 This information is provided by RNS The company news service from the London Stock Exchange END RDSNKOKPPBDDQDK
1 Year IsoPlexis Chart |
1 Month IsoPlexis Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions